AdaptHealth - AHCO Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $26.17
  • Forecasted Upside: 22.45 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$21.37
+0 (0.00%)

This chart shows the closing price for AHCO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New AdaptHealth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AHCO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AHCO

Analyst Price Target is $26.17
▲ +22.45% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for AdaptHealth in the last 3 months. The average price target is $26.17, with a high forecast of $29.00 and a low forecast of $24.00. The average price target represents a 22.45% upside from the last price of $21.37.

This chart shows the closing price for AHCO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 investment analysts is to buy stock in AdaptHealth. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 1 sell ratings
2/25/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
5/26/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 1 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 1 sell ratings
11/22/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
2/20/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/21/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/20/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/10/2022Deutsche Bank AktiengesellschaftBoost Target$22.00 ➝ $26.00Low
8/10/2022SVB LeerinkBoost TargetOutperform ➝ Outperform$24.00 ➝ $29.00Low
7/14/2022Truist FinancialBoost TargetBuy$20.00 ➝ $24.00Low
5/12/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$29.00 ➝ $26.00High
5/11/2022Deutsche Bank AktiengesellschaftLower Target$28.00 ➝ $22.00Medium
3/8/2022Royal Bank of CanadaLower TargetOutperform$31.00 ➝ $26.00High
3/2/2022SVB LeerinkLower TargetOutperform$32.00 ➝ $24.00High
2/25/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$44.00 ➝ $29.00High
2/25/2022Truist FinancialLower Target$30.00 ➝ $20.00High
2/25/2022Deutsche Bank AktiengesellschaftLower Target$34.00 ➝ $28.00High
2/25/2022Robert W. BairdLower Target$34.00 ➝ $26.00High
2/18/2022SVB LeerinkLower TargetOutperform$35.00 ➝ $32.00High
11/5/2021SVB LeerinkBoost TargetOutperform$30.00 ➝ $35.00High
10/13/2021Truist FinancialLower TargetBuy$40.00 ➝ $30.00Low
9/27/2021SVB LeerinkInitiated CoverageOutperform$30.00High
7/14/2021Robert W. BairdUpgradeNeutral ➝ Outperform$30.00 ➝ $36.00High
5/7/2021Deutsche Bank AktiengesellschaftLower TargetHold ➝ Sell$47.00 ➝ $40.00High
4/19/2021Robert W. BairdReiterated RatingOutperform ➝ Neutral$35.00N/A
4/13/2021Robert W. BairdDowngradeOutperform ➝ Neutral$35.00High
4/12/2021Robert W. BairdBoost TargetPositive ➝ Outperform$47.00 ➝ $49.00Medium
3/18/2021Truist FinancialInitiated CoverageBuy$48.00High
1/26/2021Bank of AmericaInitiated CoverageBuy$46.00Medium
12/10/2020UBS GroupInitiated CoverageBuy$49.00High
12/4/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$36.00 ➝ $47.00Low
12/2/2020SVB LeerinkBoost TargetOutperform$32.50 ➝ $39.50Low
12/2/2020Royal Bank of CanadaBoost TargetPositive ➝ Outperform$36.00 ➝ $50.00Low
11/17/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$26.00 ➝ $36.00Low
11/16/2020Robert W. BairdInitiated CoverageOutperform$35.00Low
11/5/2020SVB LeerinkBoost TargetOutperform$23.50 ➝ $32.50Medium
8/11/2020Royal Bank of CanadaBoost TargetOutperform$24.00 ➝ $33.00Medium
8/6/2020Deutsche Bank AktiengesellschaftBoost Target$10.00 ➝ $26.00Low
7/1/2020SVB LeerinkInitiated CoverageOutperform$21.00High
6/9/2020Royal Bank of CanadaInitiated CoverageOutperform$24.00Medium
5/27/2020Stifel NicolausBoost TargetBuy$18.00 ➝ $20.00Low
2/28/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$12.00 ➝ $19.00High
2/26/2020Stifel NicolausBoost TargetBuy$17.00 ➝ $18.00High
1/30/2020Stifel NicolausInitiated CoverageBuy$17.00Medium
1/7/2020Jefferies Financial GroupInitiated CoverageBuy$15.00High
12/9/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$12.00High
(Data available from 8/19/2017 forward)

News Sentiment Rating

0.28 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/21/2022
  • 1 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/20/2022
  • 2 very positive mentions
  • 11 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
3/22/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/21/2022
  • 7 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/21/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/20/2022
  • 2 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/20/2022
  • 8 very positive mentions
  • 17 positive mentions
  • 7 negative mentions
  • 1 very negative mentions
8/19/2022

Current Sentiment

  • 8 very positive mentions
  • 17 positive mentions
  • 7 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

AdaptHealth logo
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Read More

Today's Range

Now: $21.37
Low: $21.15
High: $21.54

50 Day Range

MA: $20.36
Low: $16.85
High: $25.72

52 Week Range

Now: $21.37
Low: $11.40
High: $28.75

Volume

712,252 shs

Average Volume

3,002,304 shs

Market Capitalization

$2.87 billion

P/E Ratio

41.10

Dividend Yield

N/A

Beta

0.52

Frequently Asked Questions

What sell-side analysts currently cover shares of AdaptHealth?

The following equities research analysts have issued reports on AdaptHealth in the last twelve months: Canaccord Genuity Group Inc., Deutsche Bank Aktiengesellschaft, Robert W. Baird, Royal Bank of Canada, SVB Leerink LLC, TheStreet, and Truist Financial Co..
View the latest analyst ratings for AHCO.

What is the current price target for AdaptHealth?

6 Wall Street analysts have set twelve-month price targets for AdaptHealth in the last year. Their average twelve-month price target is $26.17, suggesting a possible upside of 22.4%. SVB Leerink LLC has the highest price target set, predicting AHCO will reach $29.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $24.00 for AdaptHealth in the next year.
View the latest price targets for AHCO.

What is the current consensus analyst rating for AdaptHealth?

AdaptHealth currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AHCO will outperform the market and that investors should add to their positions of AdaptHealth.
View the latest ratings for AHCO.

What other companies compete with AdaptHealth?

How do I contact AdaptHealth's investor relations team?

AdaptHealth's physical mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The company's listed phone number is (610) 630-6357 and its investor relations email address is [email protected] The official website for AdaptHealth is www.adapthealth.com. Learn More about contacing AdaptHealth investor relations.